TCL Archive Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board June 17, 2011
TCL Archive FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer July 27, 2012
TCL Archive Also in this 8-page issue: NCI, FDA open Web site for adverse event reporting. April 16, 2004